Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fefer

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
CA: a Cancer Journal for Clinicians|January 1, 1980
Bone marrow transplants in leukemia patients in remissionA Fefer
Cancer Research|April 1, 1973
Treatment of a Moloney lymphoma with cyclophosphamide and H-2-incompatible spleen cellsA Fefer
Cancer Treatment Reviews|December 1, 1980
The biological response modifiers (BRM) program of the National Cancer InstituteA Fefer
International Journal of Cancer|May 15, 1970
Immunotherapy of primary Moloney sarcoma-virus-induced tumorsA Fefer
Clinics in Haematology|February 1, 1986
Current status of syngeneic marrow transplantation and its relevance to autograftingA Fefer
Journal of the National Cancer Institute|June 1, 1986
Allogeneic marrow transplantation for acute nonlymphoblastic leukemiaA Fefer
The Cancer Journal From Scientific American|February 11, 1998
Interleukin-2 in the treatment of hematologic malignanciesA Fefer
International Journal of Radiation Oncology, Biology, Physics|May 1, 1982
Future of bone marrow transplantation in oncologyA Fefer
Israel Journal of Medical Sciences|March 1, 1973
Adoptive tumor immunotherapy in mice as an adjunct to whole-body x-irradiation and chemotherapy. A reviewA Fefer
Transplantation|April 1, 1972
Efficacy of cryopreserved spleen cells in murine tumor immunotherapyA Fefer
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
CA: a Cancer Journal for Clinicians|January 1, 1980
Bone marrow transplants in leukemia patients in remissionA Fefer
Cancer Research|April 1, 1973
Treatment of a Moloney lymphoma with cyclophosphamide and H-2-incompatible spleen cellsA Fefer
Cancer Treatment Reviews|December 1, 1980
The biological response modifiers (BRM) program of the National Cancer InstituteA Fefer
International Journal of Cancer|May 15, 1970
Immunotherapy of primary Moloney sarcoma-virus-induced tumorsA Fefer
Clinics in Haematology|February 1, 1986
Current status of syngeneic marrow transplantation and its relevance to autograftingA Fefer
Journal of the National Cancer Institute|June 1, 1986
Allogeneic marrow transplantation for acute nonlymphoblastic leukemiaA Fefer
The Cancer Journal From Scientific American|February 11, 1998
Interleukin-2 in the treatment of hematologic malignanciesA Fefer
International Journal of Radiation Oncology, Biology, Physics|May 1, 1982
Future of bone marrow transplantation in oncologyA Fefer
Israel Journal of Medical Sciences|March 1, 1973
Adoptive tumor immunotherapy in mice as an adjunct to whole-body x-irradiation and chemotherapy. A reviewA Fefer
Transplantation|April 1, 1972
Efficacy of cryopreserved spleen cells in murine tumor immunotherapyA Fefer
Pageof 23